Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation

Journal of Clinical Investigation

Volumn 102, Issue 8, 1998, Pages 1583-1590

  Welling, Mick M ^a   Hiemstra, Pieter S ^a   Van Den Barselaar, Maria Th ^a   Paulusma Annema, Akke ^a   Nibbering, Peter H ^a   Pauwels, Ernest K J ^a   Calame, Wim ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hercules European Research Center   (Netherlands)

Author keywords

Antibacterial activity; Chemotaxis; Defensins; Infection; Leukocytes

Indexed keywords

DEFENSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; INFECTION RESISTANCE; KLEBSIELLA PNEUMONIAE; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; STAPHYLOCOCCUS INFECTION;

EID: 0032532679     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3664     Document Type: Article

References (29)

1. Hancock, R.E.W. 1997. Peptide antibiotics. Lancet. 349:418-422.
2. Ganz, T., M.E. Selsted, D. Szklarek, S.S. Harwig, K. Daher, D.F. Bainton, and R.I. Lehrer. 1985. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76:1427-1435.
3. Lehrer, R.I., A. Barton, K.A. Daher, S.S. Harwig, T. Ganz, and M.E. Selsted. 1989. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Invest. 84:553-561.
4. Lehrer, R.I., A.K. Lichtenstein, and T. Ganz. 1993. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11:105-128.
5. Territo, M.C., T. Ganz, M.E. Selsted, and R. Lehrer. 1989. Monocytechemotactic activity of defensins from human neutrophils. J. Clin. Invest. 84: 2017-2020.
6. Chertov, O., D.F. Michiel, L. Xu, J.M. Wang, K. Tani, W.J. Murphy, D.L. Longo, D.D. Taub, and J.J. Oppenheim. 1996. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271:2935-2940.
7. van Wetering, S., S.P.G. Mannesse-Lazeroms, M.A.J.A. van Sterkenburg, M.R. Daha, J.H. Dijkman, and P.S. Hiemstra. 1997. Effects of defensins on IL-8 synthesis in airway epithelial cells. Am. J. Physiol. 272:888-896.
8. van Waarde, D., E. Hulsing-Hesselink, L.A. Sandkuyl, and R. van Furth. 1977. Humoral regulation of monocytopoiesis during the early phase of an inflammatory reaction caused by particulate substances. Blood. 50:141-154.
9. 99mTc-labelled polyclonal human immunoglobulin. J. Nucl. Med. 32:468-474.
10. 99mTc-labelled polyclonal human immunoglobulin to bacteria as a mechanism for scintigraphic detection of infection. Eur. J. Nucl. Med. 18:396-400.
11. Daher, K.A., M.E. Selsted, and R.I. Lehrer. 1986. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60:1068-1074.
12. 4 and stannous chloride. Nucl. Med. Biol. 20:825-833.
13. Stolk, J., J. Camps, R.I.J. Feitsma, R. Maassen, J. Hermans, J.H. Dijkman, and E.K.J. Pauwels, 1995. Pulmonary deposition and disappearance of aerosolized secretory leucocyte protease inhibitor. Thorax. 50:645-650.
14. Calame, W., R.I.J. Feitsma, and E.K.J. Pauwels. 1992. Scintigraphic detection of inflammatory disease by various radiopharmaceuticals, especially labelled immunoglobulin. In Nuclear Medicine in Research and Practice, Vol. 28. FK Schattauer Verlag GmbH, Stuttgart, Germany. 260-269.
15. Becker, W. 1995. The contribution of nuclear medicine to the patient with infection. Eur. J. Nucl. Med. 22:1195-1211.
16. Calame, W., M.M. Welling, R.I.J. Feitsma, W.T. Goedemans, and E.K.J. Pauwels. 1995. Contribution of phagocytic cells and bacteria to the accumulation of technetium-99m labelled polyclonal human immunoglobulin at sites of inflammation. Eur. J. Nucl. Med. 22:638-644.
17. Gerber, A.U., H.P. Brugger, C. Feller, T. Stritzko, and B. Stalder. 1986. Antibiotic therapy of infections due to Pseudomonas auruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. J. Infect. Dis. 153:90-97.
18. Kunst, M.W., and H. Mattie. 1978. Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli. J. Infect. Dis. 137:391-402.
19. Lambrecht, R.M. 1996. Biological models in radiopharmaceutical development, 1st ed. In Developments in Nuclear Medicine, Vol. 27. P.H. Cox, editor. Kluwer Academic Publishers, Dordrecht, The Netherlands.
20. 99mTechnetium-labeled tracers: an optimization study. Ph.D. thesis. University of Leiden, Leiden, The Netherlands. Shaker Publishing bv. Maastricht, The Netherlands.
21. Snedecor, G.W., and W.G. Cochran. 1980. Statistical Methods, 7th ed. The Iowa State University Press, Ames, IA.
22. Polman, T.H., K.A. Stanness, and P.G. Beatty. 1986. An endothelial cell surface factor induced in vitro by LPS, IL-1 and TNF increases neutrophil adherence by a CDw 18-dependent mechanism. J. Immunol. 136:4548-4553.
23. Deakin, A.M., A.N. Payne, and B.J.R. Whittle. 1995. The modulation of IL-6 and TNF-α releases by nitric oxide following stimulation of J774 cells with LPS and IFN-γ. Cytokine. 7:408-416.
24. Nakajima, Y., J. Alvarez-Bravo, J.H. Cho, K. Homma, S. Kanegasaki, and S. Natori. 1997. Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between Chemotherapeutic activity and neutrophil activating activity. FEBS Lett. 415:64-66.
25. Ganz, T., M.E. Selsted, and R.I. Lehrer. 1990. Defensins. Eur. J. Haematol. 44:1-8.
26. Eisenhauer, P.B., and R.I. Lehrer. 1992. Mouse neutrophils lack defensins. Infect. Immun. 60:3446-3447.
27. Bals, R., M.J. Goldman, and J.M. Wilson. 1998. Mouse β-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect. Immun. 66:1225-1232.
28. Panyutich, A.V., E.A. Panyutich, V.A. Krapivin, E.A. Baturevich, and T. Ganz. 1993. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J. Lab. Clin. Med. 122:202-207.
29. Ihi, T., M. Nakazato, H. Mukae, and S. Matsukura. 1997. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin. Infect. Dis. 25:1134-1140.